Pesticide-induced systemic scleroderma: a case report
Journal of Clinical Practice · 19.03.2026 · 17 (2) · 196-206
DOI: 10.17816/clinpract689929 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Practice, online erschienen am 19.03.2026. Verfasst von Olga A. Georginova und 7 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Systemic sclerosis, or systemic scleroderma, is a rare autoimmune connective tissue disease. The presented clinical case highlights that taking an occupational history is essential in patients with suspected systemic connective tissue diseases for early detection of autoimmune disorders caused by occupational exposures and timely elimination of adverse environmental factors. This article discusses the pathophysiological mechanisms by which pesticides may induce immune disorders, promoting systemic scleroderma. CLINICAL CASE DESCRIPTION: This article presents a case of systemic scleroderma caused by prolonged occupational exposure to pesticides (cypermethrin, bromadiolone, and chlorpyrifos) used for rodent control. The condition manifested as triphasic Raynaud disease, as confirmed by nailfold capillaroscopy findings. This was followed by skin induration on the face, arms, and trunk, with a baseline modified Rodnan skin score of 28, polyarthralgia, and interstitial lung disease. Immunological tests revealed a high titer of antinuclear antibodies (1:1280) and anti-topoisomerase I antibodies (Scl-70), which was consistent with systemic scleroderma. The disease had a fluctuating course, with exacerbations following intercurrent viral infections. Immunosuppressive therapy with glucocorticoids and cytostatic agents (methotrexate, cyclophosphamide, mycophenolate mofetil) resulted in disease stabilization, with partial regression of cutaneous and visceral symptoms. CONCLUSION: The unfavorable prognosis in the presented clinical case is associated with the chronic, progressive course of the disease, with a high risk of disability, deterioration in quality of life, and decrease in life expectancy. However, timely diagnosis and adequate pathogenetic therapy can considerably delay the progression of fibrotic changes and improve the prognosis.
Zitieren
APA
Georginova, O. A., Grishanina, E. A., Michurina, A. A., Makarov, E. A., Avdeev, V. G., Strizhakov, L. A., Krasnova, T. N., & Seredenina, E. M. (2026). Pesticide-induced systemic scleroderma: a case report. Journal of Clinical Practice, 17(2), 196-206. https://doi.org/10.17816/clinpract689929
Vancouver
Georginova OA, Grishanina EA, Michurina AA, Makarov EA, Avdeev VG, Strizhakov LA, et al. Pesticide-induced systemic scleroderma: a case report. Journal of Clinical Practice. 2026;17(2):196-206. doi:10.17816/clinpract689929
BibTeX
@article{Georginova2026,
author = {Georginova, Olga A. and Grishanina, Ekaterina A. and Michurina, Antonina A. and Makarov, Egor A. and Avdeev, Vladimir G. and Strizhakov, Leonid A. and Krasnova, Tatyana N. and Seredenina, Elena M.},
title = {Pesticide-induced systemic scleroderma: a case report},
journal = {Journal of Clinical Practice},
year = {2026},
volume = {17},
number = {2},
pages = {196--206},
doi = {10.17816/clinpract689929}
}
EUVIMED